Health Products

Teva-Tolterodine (2016-08-04)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
0T3003B. Teva-Tolterodine 2mg
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
TabletDIN 022996072mg
0T2003A. Teva-Tolterodine 1mg
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
TabletDIN 022995931mg

Introduction

Affected products
  1. Teva-Tolterodine 1mg
  2. Teva-Tolterodine 2mg

Reason

Presence of fungal/mold organisms traced to raw material used in the formulation.

Depth of distribution

Pharmacies and Wholesalers Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime